Understanding how bacteria protect themselves from viruses using CRISPR technology
Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems
This study looks at how certain bacteria use a special immune system to fight off viruses, and by understanding how they remember past infections, we hope to find new ways to help treat tough bacterial infections that don't respond to antibiotics.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project ID | NIH-11000346 on NIH RePORTER |
What this research studies
This research investigates how certain bacteria use a unique immune system called CRISPR-Cas to defend against viral infections. By examining the mechanisms that allow bacteria to remember past infections and adapt their defenses, the study aims to uncover the specific processes involved in this immune response. The research focuses on the type II-A CRISPR systems, which have distinct properties that could lead to new biotechnological applications. Patients may benefit from advancements in treating antibiotic-resistant bacterial infections through improved understanding of these mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with viral infections that are not bacterial in nature may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for combating antibiotic-resistant bacterial infections.
How similar studies have performed: Previous research has shown promise in understanding CRISPR mechanisms, indicating potential for success in this area of investigation.
Where this research is happening
Norman, United States
- University of Oklahoma — Norman, United States (Active)
Researchers
- Principal investigator: Rajan, Rakhi — University of Oklahoma
- Study coordinator: Rajan, Rakhi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.